Addison's disease affects an estimated 1 in 100,000 people in the United States, yet diagnostic delay is the central clinical failure: up to 50% of patients first present in adrenal crisis, and roughly 40% are diagnosed more than six months after symptom onset. Because the adrenal glands lose most of their reserve before symptoms appear, the presentation is insidious, and any physiologic stressor can precipitate a life-threatening crisis. Recognizing the disease as dual-hormone loss, not simply low cortisol, and documenting it precisely are among the highest-value clinical actions a primary care team can take.
AAVBC's Addison's Disease Quick Reference Guide equips primary care clinicians and care teams with a comprehensive, evidence-aligned reference covering ICD-10 coding specificity across primary, crisis, and drug-induced adrenal insufficiency, HCC/RAF V28 mapping, diagnostic thresholds for morning cortisol and ACTH testing, MEAT documentation standards, therapy escalation and stress-dosing protocols, comorbidity and cardiovascular risk screening, and referral and follow-up timing. Grounded in Endocrine Society and 2024 ESE/Endocrine Society joint guidance, this guide supports consistent, individualized clinical decision-making, helping care teams recognize adrenal insufficiency before it reaches crisis and document its complexity completely, with the clarity and continuity that durable outcomes require.
AAVBC’s Deep-Dive series offers a comprehensive, structured analysis of Addison's disease — moving far beyond quick-reference essentials. These guides provide an integrated review of epidemiology, diagnostic strategy, staging, coding logic, MEAT-aligned documentation examples, treatment guidelines, review vulnerabilities, and cost-utilization considerations. The Deep-Dive combines evidence-informed clinical guidance with practical operational tools to support a deeper understanding of disease complexity and provide multidisciplinary teams with strategies to thrive within value-based frameworks.
Addison's disease affects an estimated 1 in 100,000 people in the United States, yet diagnostic delay is the central clinical failure: up to 50% of patients first present in adrenal crisis, and roughly 40% are diagnosed more than six months after symptom onset. Because the adrenal glands lose most of their reserve before symptoms appear, the presentation is insidious, and any physiologic stressor can precipitate a life-threatening crisis. Recognizing the disease as dual-hormone loss, not simply low cortisol, and documenting it precisely are among the highest-value clinical actions a primary care team can take.
AAVBC's Addison's Disease Quick Reference Guide equips primary care clinicians and care teams with a comprehensive, evidence-aligned reference covering ICD-10 coding specificity across primary, crisis, and drug-induced adrenal insufficiency, HCC/RAF V28 mapping, diagnostic thresholds for morning cortisol and ACTH testing, MEAT documentation standards, therapy escalation and stress-dosing protocols, comorbidity and cardiovascular risk screening, and referral and follow-up timing. Grounded in Endocrine Society and 2024 ESE/Endocrine Society joint guidance, this guide supports consistent, individualized clinical decision-making, helping care teams recognize adrenal insufficiency before it reaches crisis and document its complexity completely, with the clarity and continuity that durable outcomes require.
AAVBC’s Deep-Dive series offers a comprehensive, structured analysis of Addison's disease — moving far beyond quick-reference essentials. These guides provide an integrated review of epidemiology, diagnostic strategy, staging, coding logic, MEAT-aligned documentation examples, treatment guidelines, review vulnerabilities, and cost-utilization considerations. The Deep-Dive combines evidence-informed clinical guidance with practical operational tools to support a deeper understanding of disease complexity and provide multidisciplinary teams with strategies to thrive within value-based frameworks.
